Acquisition with 11C-choline and 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Acquisition with 11C-choline and 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis

Published:2016-05-12 Issue:6 Volume:30 Page:385-392
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

von Eyben Finn E.,Kairemo Kalevi

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12149-016-1078-7.pdf

Reference33 articles.

1. von Eyben FE, Kairemo K. Meta-analysis of (11)C-choline and (18)F-choline PET/CT for management of patients with prostate cancer. Nucl Med Commun. 2014;35:221–30.

2. Chan J, Syndikus I, Mahmood S, Bell L, Vinjamuri S. Is choline PET useful for identifying intraprostatic tumour lesions? A literature review. Nucl Med Commun. 2015;36:871–80.

3. Simone G, Di Pierro GB, Papalia R, et al. Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with (1)(8)F-fluorocholine positron emission tomography/computed tomography. World J Urol. 2015;33:1511–8.

4. Massaro A, Ferretti A, Secchiero C, et al. Optimising (18)F-choline PET/CT acquisition protocol in prostate cancer patients. N Am J Med Sci. 2012;4:416–20.

5. Chondrogiannis S, Marzola MC, Grassetto G, et al. Optimized protocol for (18)F-choline PET/CT in patients with biochemically relapsed prostate cancer: experiences on 250 consecutive cases. Clin Nucl Med. 2015;40:e308–12.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multitargeted polypharmacotherapy for cancer treatment. theoretical concepts and proposals;Expert Review of Anticancer Therapy;2024-07-08

2. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature;European Urology Oncology;2024-02

3. Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU);Cancer Treatment Reviews;2023-11

4. Piflufolastat F-18 (¹⁸F-DCFPyL) for PSMA PET imaging in prostate cancer;Expert Review of Anticancer Therapy;2022-06-28

5. PET/CT in Prostate Cancer;Artificial Intelligence in PET/CT Oncologic Imaging;2022